Pharmaxis Ltd (AU:SNT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Syntara Ltd has successfully raised A$15 million through a two-tranche placement, bolstering its cash reserves to approximately A$21.7 million. This capital will support various clinical trials and drug development initiatives, including those for myelofibrosis and Parkinson’s, as well as general operational expenses. The strong backing from institutional and high net worth investors reflects confidence in Syntara’s ongoing research and development programs.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
